Učitavanje...
Contributions of KRAS and RAL in Non-Small Cell Lung Cancer growth and progression
INTRODUCTION: KRAS mutations are poor prognostic markers for patients with non-small cell lung cancer (NSCLC). RALA and RALB GTPases lie downstream of RAS and are implicated in RAS mediated tumorigenesis. However, their biological or prognostic role in the context of KRAS mutation in NSCLC is unclea...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3934792/ https://ncbi.nlm.nih.gov/pubmed/24389431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000007 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|